| Date | Title | | | 04/30/12 | Luminex Corporation Reports First Quarter 2012 Results| Revenue Growth of 13 percent over prior year
AUSTIN, Texas, April 30, 2012 /PRNewswire/ -- Luminex Corporation (NASDAQ:LMNX) today announced financial results for the first quarter ended March 31, 2012. Financial and operating highlights include the following:
Consolidated first quarter revenue was $48.7 million, a 13 percent increase over the first quarter of 2011
First quarter assay revenue was $17.3 million, a 80 percent increase over the first quarter of 2011
Fi... |
|  | | 04/26/12 | Luminex Corporation Receives CE Mark for Revolutionary Newborn Screening Platform| xMAP® NeoPlex4® Assay and Automated System Set New Standard in Neonatal Care
AUSTIN, Texas, April 26, 2012 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) announced today that it has received CE marking of both the xMAP NeoPlex4 Assay and NeoPlex® System. This unique system revolutionizes the way newborn screening is performed, providing four assays from one blood spot punch, reducing sample requirements and improving laboratory efficiency.
(Logo: http://photos.prnewswire.com/prnh/... |
| | | 04/24/12 | Luminex Corporation Expands Life Science and Biodefense Groups| Two Dedicated Groups Advance Luminex Leadership in Scientific Research and Public Safety
AUSTIN, Texas, April 24, 2012 /PRNewswire via COMTEX/ --Luminex Corporation (NASDAQ: LMNX) today announced the expansion of two dedicated groups within its organization: the Life Science and the Biodefense Groups, each with focused initiatives on the development of Luminex technology into these important market segments. While already participating in these markets, further investment in these groups p... |
| | | 04/09/12 | Luminex Corporation First Quarter Earnings Release Scheduled for April 30, 2012|
AUSTIN, Texas, April 9, 2012 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) today announced that it expects to report results for the first quarter of 2012 on Monday, April 30, 2012. A press release announcing the results is scheduled for release after the close of trading.
(Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO)
Management will hold a conference call to discuss the operating highlights and financial results for the first quarter ended March 31, 2012 on Apr... |
| | | 04/03/12 | Luminex and Bio-Rad Extend Their Global Sales and Distribution Agreement to 2023| The Partnership Provides Expanded Access to the Award Winning MAGPIX® Multiplexing Instrument
AUSTIN, Texas, April 3, 2012 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it has extended its global sales and distribution agreement with Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) to 2023. In addition, Luminex has granted Bio-Rad global sales and distribution rights for Luminex's award-winning MAGPIX multiplexing instrument.
(Logo: http://photos.prnewswire.com/... |
| | | 03/28/12 | Luminex Corporation to Speak at Joint Department of Defense and Environmental Protection Agency 5th National Bio-Threat Conference| Dr. Amy Altman to Highlight Innovative Use of MAGPIX® for Bio-Threat and Infectious Disease Detection
AUSTIN, Texas, March 28, 2012 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced Dr. Amy Altman, vice president of Biodefense will present at the 5th National Bio-Threat Conference, taking place March 27-29, 2012 in Denver, Colorado. The meeting is sponsored by the Department of Defense's Joint Program Executive Office for Chemical and Biological Defense, Joint... |
| | | 02/09/12 | Luminex Corporation to Present at Upcoming Investment Conferences in February and March|
AUSTIN, Texas, Feb. 9, 2012 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) announced today that management will present at two upcoming investment conferences, the Leerink Swann 2012 Global Healthcare Conference and the Cowen and Company 32nd Annual Health Care Conference.
(Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO)
Patrick J. Balthrop, president and chief executive officer, will present at the Leerink Swann 2012 Global Healthcare Conference on Febru... |
| | | 02/06/12 | Luminex Corporation Reports Fourth Quarter and Full Year 2011 Results| Luminex achieves 30 percent annual revenue growth
AUSTIN, Texas, Feb. 6, 2012 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced financial results for the fourth quarter and year ended December 31, 2011. Financial and operating highlights include the following:
(Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO)
Consolidated fourth quarter 2011 revenue was $47.9 million, a 16 percent increase over the fourth quarter of 2010; full-year 2011 revenue was $1... |
| | | 01/16/12 | Luminex Corporation Fourth Quarter and Full Year 2011 Earnings Release Scheduled for February 6, 2012|
AUSTIN, Texas, Jan. 16, 2012 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) today announced that it expects to report results for the fourth quarter and full year 2011 on Monday, February 6, 2012. A press release announcing the results is scheduled for release after the close of trading.
(Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO)
Management will hold a conference call to discuss the operating highlights and financial results for the fourth quarter... |
| | | 01/04/12 | Luminex Corporation to Present at JP Morgan Healthcare Conference| AUSTIN, Texas, Jan. 4, 2012 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that management will present at the 30th Annual JP Morgan Healthcare Conference to be held January 9 -12, 2012, in San Francisco, CA.
(Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO)
The investor presentation by Patrick J. Balthrop, president and chief executive officer, will begin at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) on Wednesday, January 11, 2012. The presentation ... |
| |
|
RSS
